Free access
Spotlight Selection
Spotlight
15 September 2010

Articles of Significant Interest Selected from This Issue by the Editors

A Novel Peptide Inhibiting Human Immunodeficiency Virus Type 1 Entry

Human immunodeficiency virus type 1 (HIV-1) gp41 plays a critical role in the viral fusion process and serves as an important target for anti-HIV-1 drug development. Zhu et al. (p. 9359-9368) identified a novel gp41 core-binding molecule, designated P20, which is effective at blocking HIV-1 Env-mediated syncytium formation and inhibiting infection by a broad spectrum of HIV-1 strains with distinct subtypes and coreceptor tropism. Therefore, this peptide can be used for developing novel HIV fusion inhibitors and as a probe for studying the membrane fusogenic mechanism of HIV.

The Proteasome as an In Vivo Target of Hepatitis B Virus HBX Protein

Hepatitis B virus (HBV) requires the HBX gene for productive infection, but its precise role remains elusive. Zhang et al. (p. 9326-9331) show that the proteasome complex is important for HBX function. A proteasome inhibitor markedly enhances the replication of HBV defective for HBX but has a minor effect on wild-type HBV replication in two in vivo models. This work suggests that HBX inhibits proteasome activities that may interfere with HBV replication, thus providing a potential target for anti-HBV therapeutics.

Varicella-Zoster Virus IE62 Protein Inhibits Beta Interferon Induction by Blocking IRF3 Function

Varicella-zoster virus (VZV) modulates cytokine signaling pathways by regulating activation of cellular transcription factors. Sen et al. (p. 9240-9253) show that VZV can inhibit beta interferon (IFN-β) and ISG induction by inhibiting TBK1-mediated IRF3 activation via the IE62 protein. This work has led to the identification of a new function for IE62 in VZV infection. IE62 is suggested to be a viral “sink” that depletes both the kinase (TBK1) and substrate (IRF3) required for optimal IFN-β induction. The observations reported describe a novel mechanism of IFN-β inhibition among herpesviruses.

Mechanisms of Protection against Influenza Virus Infection by Memory CD4 T Cells

Memory CD4 T cells persist after influenza virus infection and vaccination in humans, although their protective potential remains undefined. Teijaro et al. (p. 9217-9226) demonstrate, using a mouse model, that influenza virus-specific memory CD4 T cells can direct enhanced viral clearance in the lungs and protection against lethal challenge in the absence of B cells or CD8 T cells through a gamma interferon-dependent mechanism. These results indicate that secondary responses by memory CD4 T cells are independent of helper functions, with important implications for designing cross-protective vaccines through targeting the generation of long-lived memory CD4 T cells.

Particle Stability of Virions Purified from Extreme Environments

Sulfolobus turreted icosahedral virus experiences an extracellular environment of near boiling acid. Khayat et al. (p. 9575-9583) describe treatments that (i) strip a single type of protein from the pentameric turrets, altering interactions of the major capsid protein (MCP) with an internal membrane; (ii) remove the turrets and much of the MCP, forming partially decorated, genome-containing, phosolipid spheres; or (iii) remove all protein from the phospholipid, leaving a putative entry intermediate prepared to fuse with cellular membranes for double-stranded DNA delivery. These studies offer insights into the properties of virus particles that ensure survival in harsh extracellular environments while favoring efficient and controlled intracellular virion disassembly.

Information & Contributors

Information

Published In

cover image Journal of Virology
Journal of Virology
Volume 84Number 1815 September 2010
Pages: 8997

History

Published online: 15 September 2010

Permissions

Request permissions for this article.

Contributors

Metrics & Citations

Metrics

Note:

  • For recently published articles, the TOTAL download count will appear as zero until a new month starts.
  • There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.
  • Citation counts come from the Crossref Cited by service.

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

View Options

Figures

Tables

Media

Share

Share

Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy